Keeping Current CME podkast

New Standards in Diffuse Lower-Grade Gliomas: Integrative Management From Surgery to Survivorship

0:00
25:32
Do tyłu o 15 sekund
Do przodu o 15 sekund

Which patients with IDH-mutant glioma should receive an isocitrate dehydrogenase (IDH) inhibitor? A top neurosurgeon weighs in.

Credit available for this activity expires: 6/9/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002598?ecd=bdc_podcast_libsyn_mscpedu

Więcej odcinków z kanału "Keeping Current CME"